Top 10 IVF Marketing Agencies India 2026 — ART Act + CPQL Comparison | ICG

Author: ICG Editorial · July 2026

Conflict of interest disclosure: ICG manages IVF marketing for 57 fertility clinic clients and is ranked #1 on this list. The methodology is objective and applied equally to all agencies. Readers are encouraged to independently verify all claims.

IVF-specific evaluation criteria

IVF marketing agencies face requirements that do not apply to general healthcare marketing agencies:

ART Act 2021 Section 26 compliance: Does the agency know that Section 26 prohibits specific success rate advertising? Have any of their IVF clients received ART Registry or NMC complaints about their advertising? Zero is the standard ICG holds itself to.

90-180 day attribution window: Does the agency use extended attribution windows matching the IVF consideration cycle, or do they use standard 7-day Google and 7-day Meta attribution? Standard windows systematically undervalue top-of-funnel IVF campaigns.

Archetype-specific campaign architecture: Do they run separate campaigns for primary infertility, secondary infertility, male-factor infertility, and international diaspora? Or a single "IVF clinic" campaign?

Hawk-equivalent re-engagement: Do they have a CRM re-engagement programme for IVF limbo leads? In a 90-180 day consideration cycle, 28-34% of leads go limbo. An agency without a re-engagement programme is abandoning approximately 30% of media budget output.

International diaspora programme: Gulf-targeted Arabic + English programme? UK/USA NRI programme? Bangladesh Bengali programme? These represent significant IVF patient volumes at higher lifetime value than domestic patients.

The top 10 IVF marketing agencies

#1 — ICG (Ichelon Consulting Group)

IVF portfolio: 57 active IVF clients across 14 cities · India + Gulf + UK + Bangladesh

CPQL trajectory (ICG reference engagement, Chandigarh IVF clinic): CPQL ₹1,840 at engagement start → ₹980 in 20 weeks. Consultation growth: +67%.

Key differentiators to assess for any IVF agency:

1. Can they explain the ART Act Section 26 prohibition without prompting? Ask directly: "What does Section 26 of the ART Act 2021 say about IVF advertising?" A correct answer: "It prohibits advertising success rates, identifying donors, and promoting commercial surrogacy." An incorrect answer or blank look: the agency is not IVF-compliant.

2. What attribution window do they use for IVF Google Ads? Correct: "We use a 90-180 day attribution window via server-side conversion API." Incorrect: "We use Google's standard 7-day click window." The 7-day window misattributes 60-70% of IVF conversions.

3. How do they handle the 30% limbo lead problem for IVF? Correct: structured re-engagement sequence over 90 days (Hawk or equivalent), targeting the 28-34% of leads in limbo at day 30. Incorrect: "We hand leads over to the clinic for follow-up." Handing leads without a managed re-engagement system loses 30% of media budget output.

4. Do they run IVF international diaspora programmes? Correct: separate Meta campaigns targeting Gulf diaspora (Arabic + English creative), separate landing pages for international patients, WhatsApp Arabic-language first response. Incorrect: "We geo-target broadly and let international patients find us."

CPQL benchmarks: what each agency tier should deliver

FAQ

Q1: Should I work with an IVF-specialist agency or a general healthcare marketing agency for my fertility clinic? IVF-specialist depth within a broader healthcare agency is the ideal. Pure IVF-specialist agencies (if they exist) may lack the technology infrastructure (CAPI, CRM integration, attribution) of larger healthcare agencies. A healthcare agency with 10+ IVF clients has both the specialty depth and the technology infrastructure. ICG's 57 IVF clients represent the largest IVF marketing portfolio in India.

Q2: How important is the agency's ART Act knowledge for my clinic? Critical. A single ART Act Section 26 violation (publishing a specific success rate in an ad) can result in ART Registry action and NMC referral. In a competitive IVF market where competitor-filed complaints are increasingly common, a non-compliant ad is not just a compliance risk — it is a competitive risk. ICG has zero ART Act complaints across 57 IVF clients since 2018.

Q3: What should my IVF Google Ads CPQL be in month 1 vs month 6? Month 1 (pre-CAPI, learning phase): ₹1,800-2,400. Month 3 (post-CAPI, algorithm learning): ₹1,200-1,600. Month 6 (stable, Hawk active): ₹980-1,180 (approaching ICG portfolio median). If your CPQL has not improved from month 1 to month 6, the campaign architecture or attribution is the problem — not the market.

Compliance note: ART Act 2021 Section 26, NMC Section 6, DPDP Act 2023.